RxDoctor Payments Data

Kelli Baender, MD

Procedural Dermatology · Atlanta, GANPI 1093793416

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,340 of the $9,790 with a category attached, or 85.2%. It is spread thinly across 34 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,843 and has fallen 91.1% since, to $253 in 2025.

$9,790in general payments, 2019–2025

Across 358 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$2K
  • Regeneron Healthcare Solutions, Inc.$549
  • Sanofi$545
  • LEO Pharma Inc.$532
  • UCB, Inc.$465
  • plus $4K from 28 others

What the payments were for

  • Consulting fees$1,35014%
  • Food & beverage$8,34085%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$222,498
Medicare patients
861
Services billed
3,814

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate50$1,682
Triamcinolone Acetonide67$832
Metronidazole15$778
Fluocinonide19$705
Clindamycin Phosphate14$583
Betamethasone Dipropionate17$548
Fluorouracil11$538
Doxycycline Hyclate21$532
Desonide12$489
Fluocinolone Acetonide15$481
Ketoconazole27$223
ValacyclovirValacyclovir Hcl11$216
Mupirocin37$203
Gentamicin Sulfate11$193
Hydrocortisone17$102

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →